The effect of pneumococcal immunization on total and antigen-specific B cells in patients with severe chronic kidney disease
Abstract Background While the 23-valent pneumococcal polysaccharide vaccine (PPV23) is routinely used in Canada and some other countries to prevent pneumococcal infection in adults with chronic kidney disease (CKD), patients develop a suboptimal antibody response to PPV23 due to their immune dysfunc...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-11-01
|
Series: | BMC Immunology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12865-019-0325-9 |